B Cell Biomarkers of Rituximab Responses in Systemic Lupus ErythematosusVITAL, Edward M; DASS, Shouvik; BUCH, Maya H et al.Arthritis and rheumatism. 2011, Vol 63, Num 10, pp 3038-3047, issn 0004-3591, 10 p.Article

Clinical outcomes, quality of life, and diagnostic uncertainty in the first year of polymyalgia rheumaticaHUTCHINGS, Andrew; HOLLYWOOD, Jane; GENDI, Nagui et al.Arthritis care and research. 2007, Vol 57, Num 5, pp 803-809, issn 0893-7524, 7 p.Article

Evidence for a different anatomic basis for joint disease localization in polymyalgia rheumatica in comparison with rheumatoid arthritisMARZO-ORTEGA, Helena; RHODES, Laura A; MCGONAGLE, Dennis et al.Arthritis and rheumatism. 2007, Vol 56, Num 10, pp 3496-3501, issn 0004-3591, 6 p.Article

Diagnosing late onset rheumatoid arthritis, polymyalgia rheumatica, and temporal arteritis in patients presenting with polymyalgic symptoms. A prospective longterm evaluationPEASE, Colin T; HAUGEBERG, Glenn; MORGAN, Ann W et al.Journal of rheumatology. 2005, Vol 32, Num 6, pp 1043-1046, issn 0315-162X, 4 p.Article

Polymyalgia Rheumatica (PMR) Special Interest Group at OMERACT 11: Outcomes of Importance for Patients with PMRMACKIE, Sarah L; ARAT, Seher; WALSH, Maggie et al.Journal of rheumatology. 2014, Vol 41, Num 4, pp 819-823, issn 0315-162X, 5 p.Article

Ischaemic manifestations in giant cell arteritis are associated with area level socio-economic deprivation, but not cardiovascular risk factorsMACKIE, Sarah L; DASGUPTA, Bhaskar; PEASE, Colin T et al.Rheumatology (Oxford. Print). 2011, Vol 50, Num 11, pp 2014-2022, issn 1462-0324, 9 p.Article